GENEVA RECORD: Open Payments
NPI 1003297078 · RINGGOLD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 27 payments from 14 companies in 2025. Trend: 2023 $645 · 2024 $776 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $265 |
| Sumitomo Pharma America, Inc. | 2 | $126 |
| Kowa Pharmaceuticals America, Inc. | 1 | $125 |
| HEARTFLOW, INC. | 1 | $78 |
| Astellas Pharma US Inc | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Lundbeck LLC | 1 | $29 |
| ABBVIE INC. | 2 | $28 |
Products named: Ozempic, GEMTESA, ZORYVE, FFRct, Wegovy, Veozah, JARDIANCE, REXULTI.
Industry payments across GA — which companies pay providers there.
